|
|
|
| Name |
| Corte-Real, Sofia |
|
| Nationality |
| Portuguese |
| E-Mail |
| scortereal@yahoo.com |
|
| 1st Degree |
| Applied Chemistry |
|
| University (1st Degree) |
| UNL-FCT |
|
| About the PhD |
| Field of Research |
| Antibodies and Virology |
|
| Thesis Title |
| Intracellular Antibodies for Inhibition of Latency Associated Nuclear Antigen from Kaposi’s Sarcoma Associated Herpesvirus |
|
| Supervisor(s) |
| João Gonçalves |
|
| University |
| Faculty of Pharmacy University of Lisbon |
|
| Laboratory |
| URIA/CPM |
|
| City |
| Lisbon |
|
| Country |
| Portugal |
|
| Date of Thesis Defence |
| 2005-06-27 |
|
| After the PhD (Current Situation) |
| Position |
| R&D Director |
|
| Project |
| TechnoAntibodies |
|
| Institution |
| Technophage,SA |
| View Institution website |
|
| City |
| Lisbon |
|
| Country |
| Portugal |
|
|
| Relevant Publications |
|
S. Corte-Real, L. Fonseca, C Barbas, Y Chang, P Moore, J. Gonçalves.
Intrabody-based mapping of Latency-Associated Nuclear Antigen from Kaposi’s Sarcoma-
Associated Herpesvirus show conserved epitopes for viral latency inhibition.
Virology: Research and Treatment 2010:2; 1-16
|
|
Book Chapter
Sofia Corte-Real, Frederico Aires da Silva and Joao Goncalves.
Chapter16- Development of Antibody Fragments for Therapeutic Applications
Castanho, M. / Santos, N. (eds.)
Peptide Drug Discovery and Development
Translational Research in Academia and Industry
Wiley-VCH Verlag GmbH & Co. KG (2011)
|
|
Aires da Silva F, Costa MJ, Corte-Real S, Goncalves J.
Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies.
Hum Gene Ther. 2005 Feb;16(2):223-34. |
|
Corte-Real S, Collins C, Aires da Silva F, Simas JP, Barbas CF 3rd, Chang Y, Moore P, Goncalves J.
Intrabodies targeting the Kaposi sarcoma-associated herpesvirus latency antigen inhibit viral persistence in lymphoma cells.
Blood. 2005 Dec 1;106(12):3797-802. Epub 2005 Aug 9. |
|
S. Corte-Real , L.Fonseca and J. Gonçalves.
KSHV latency in transformed B- cells: The role of LANA1 as a therapeutic target.
Virology: Research and Treatment 2008:1; Review 1-6
|
|
Frederico Aires da Silva , Sofia Corte-Real and Joao Goncalves.
Recombinant antibodies as therapeutic agents. Pathways for modelling new biodrugs.
Biodrugs 2008;22(5):1
|
| Last Update |
| 2014-04-13 10:22:25 |
| The responsibility for this page contents is entirely of the student/alumnus. |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
Program financially supported by
the National Foundation for
Science and Technology
|
|
 |
|
